Testing a new inhaled medication for lung disease with high blood pressure

This trial is testing a new medication called mosliciguat, which you would inhale daily, to see if it is safe and effective when combined with your current inhaled treprostinil treatment. The study focuses on people who have both interstitial lung disease (a condition where lung tissue becomes scarred and stiff) and pulmonary hypertension (high blood pressure in the lungs). Researchers want to learn whether adding this medication to your existing treatment can help you breathe better and feel stronger.

Currently, there are limited treatment options for people who have both of these lung conditions at the same time. This trial exists to see if this medication could offer a new option that might improve how well people with this combination of diseases can function and exercise.